Sun, Dec 21, 2014, 12:32 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • starfe11 starfe11 Oct 18, 2012 7:46 AM Flag

    Where we are & what we're doing

    PPMD makes it a priority to attend the most important meetings and conferences related to Duchenne, as well as connecting with the leaders in the field to move research, care, and advocacy forward.

    See where we’ve been and where we are going:
    10/10: Holly attended Colorado FACES meeting
    10/10: Holly attended Therapeutic Misconcetions meeting
    10/10: Sharon attended ImagingDMD Meeting
    10/15: Sharon attends Society for Neuroscience meeting
    10/22-24: Pat and Ryan attend NORD meeting
    10/27: Pat and Sharon attend TACT meeting
    10/29-30: Ryan attends BIO meeting
    11/2-4: Pat attends NORD board meeting
    11/4-6: Holly attends Therapeutic Misconceptions meeting
    11/9: Sharon meets with Drug Development Committee
    11/10: Sharon attends CINRG meeting
    11/10: Pat and Ryan attend FACES Pacific Northwest meeting
    11/28: Pat attends Orphan Drugs in Rare Diseases meeting
    11/28-30: Sharon presents at Partnering for Cures meeting

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SRPT
13.21-0.59(-4.28%)Dec 19 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.